Category
Primary
pharmaceutical-drugs · embed-ft 0.53
Tree path
Medical Health › Pharmaceutical Drugs
Group (tier-1)
Tech stack
CMS
Analytics
CDN
Consent/CMP
AI readiness
AI training policy
reserved
AI-bot protection
Blocked AI bots
AI files
Evidence
robots:GPTBot+Meta-ExternalAgent+Amazonbot+Applebot-Extended+Bytespider+CCBot+ClaudeBot+Google-Extended
Compliance (GEO / GDPR)
TLD
Overview
Title
UNLOXCYT™ (cosibelimab-ipdl) Injection 300 mg | cSCC Information
Description
Learn about UNLOXCYT, indicated for the treatment of metastatic cutaneous squamous cell carcinoma (cSCC) in adults. Please see full Prescribing Information and Important Safety Information.
Final URL
Language
en (html)
Scanned at
2026-06-29 05:26:04